Bank Central Asia Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Bank Central Asia Tbk trades at Rp6,225 (market cap 753.61T, 180.06M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 1.44M 24h volume). The key difference: Bank Central Asia Tbk is far larger — about 1289.1× UBC Medical Indonesia Tbk.'s market cap, and Bank Central Asia Tbk is more actively traded (180.06M versus 1.44M). Which is the better fit depends on your goals.
| BBCA | LABS | |
|---|---|---|
Market Cap | 753.61T | 584.6B |
Volume | 180.06M | 1.44M |
Lot | 1.8M | 14.4K |
Turnover | 1.11T | 209.72M |
Average Price | 6,176.89 | 145.64 |
Value | 1.11T | 209.72M |
Indicative Equilibrium Price | 6,225 | 146 |
Indicative Equilibrium Volume | 292.85K | 753 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Bank Central Asia, Tbk (the Company) was established under the name of N.V. Perseroan Dagang Dan Industrie Semarang Knitting Factory based on notarial deed No. 38 of Raden Mas Soeprapto dated 10 August 1955, which was then changed to PT Bank Central Asia based on notarial deed No. 144 of Ridwan Suselo dated 21 May 1974.
Read more on BBCA →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →